Whittier Trust’s Alder Biopharmaceuticals ALDR Stock Holding History
Bought
Maintained
Sold
Whittier Trust's ALDR Position: Q4 2019 in Review
Whittier Trust sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 271 shares — an estimated $5K sold.
Whittier Trust first reported a position in ALDR in Q3 2019 and held it in 1 quarter. The position peaked at $5K in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.
- Whittier Trust reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
- Whittier Trust sold 271 Alder Biopharmaceuticals shares in Q4 2019, an estimated $5K.
- Whittier Trust first reported a position in Alder Biopharmaceuticals in Q3 2019 and held it in 1 quarter.
- Whittier Trust's Alder Biopharmaceuticals position peaked at $5K in Q3 2019.
- 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.
Based on Whittier Trust's 13F filing for Q4 2019, filed 31 Jan 2020.